Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
1 other identifier
observational
75
1 country
3
Brief Summary
The objective of this observational study is to explore the structure of biliary flora in normal people, explore the dynamic impact of ERCP and EST on biliary microecology, study the marker flora, metabolites and functional genes related to biliary diseases, explore the occurrence and development mechanism, regulatory pathways and key targets of biliary diseases, and provide new strategies for the prevention and treatment of biliary diseases from the perspective of biliary microecology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 20, 2022
CompletedFirst Posted
Study publicly available on registry
October 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedMarch 20, 2023
March 1, 2023
9 months
October 20, 2022
March 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Successfully collect all bile samples required
Collect the required bile samples under the required conditions according to the difference of the three groups.Then DNA extraction, Illumina MiSeq sequencing and bioinformatics analysis will be performed on the collected samples.
1 week
Study Arms (3)
Patients with Gallbladder polyp or gallbladder adenomyosis
Patients with Gallbladder polyp or gallbladder adenomyosis In view of the difficulty in obtaining bile from normal people, our research team plans to select bile samples from patients undergoing laparoscopic cholecystectomy and patients with pathological diagnosis of gallbladder polyps or gallbladder adenomyosis as physiological bile of normal people.
Patients with choledocholithiasis
Patients with choledocholithiasis The research group plans to select bile samples from patients with first episode choledocholithiasis, patients receiving ERCP treatment for the first time, and patients undergoing duodenal papillary incision during EST operation to study the biliary flora of patients with choledocholithiasis. Compared with the normal group, analyze whether there are differences, similarities and uniqueness between the groups, dynamically track changes in the structure of biliary flora before and after treatment, and whether there is specific flora related to the type of disease, and compared with the existing biliary microbiome database, to study whether there are new bacterial species.
Patients with previous ERCP and/or EST operations and duodenal papilla incision during operation
Patients with previous ERCP and/or EST operations and duodenal papilla incision during operation Bile from patients who had undergone ERCP and EST duodenal papillary incision was collected, and the long-term impact of duodenal papillary incision on biliary microecology was discussed by comparing with that of normal patients.
Interventions
This project systematically studies the physiological characteristics of biliary microecology in normal people, and explores the impact of ERCP and EST duodenal papillary incision on biliary microecology.
Eligibility Criteria
1. Patients with Gallbladder polyp or gallbladder adenomyosis 2. Patients with choledocholithiasis 3. Patients with previous ERCP and/or EST operations and duodenal papilla incision during operation
You may qualify if:
- The patient received laparoscopic cholecystectomy in our hospital from September 1, 2022 to September 1, 2023;
- Age\>18 years old;
- Postoperative pathology was gallbladder polyp or gallbladder adenomyosis.
You may not qualify if:
- Preoperative biliary surgery history or intraoperative biliary injuried;
- Other complications were found.
- Patients with choledocholithiasis:
- The patients were treated in our center from September 1, 2022 to September 1, 2023;
- Age\>18 years old;
- Patients with choledocholithiasis received ERCP and EST treatment for the first time, but did not receive treatment in other hospitals;
- The nasobiliary duct is to be retained to drain bile.
- Acute cholangitis;
- There are serious complications.
- Patients with previous ERCP and/or EST operations and duodenal papilla incision during operation:
- The patients received ERCP treatment in our center from September 1, 2022 to September 1, 2023;
- Age\>18 years old;
- He has had ERCP and EST operations in the past, and the duodenal papilla was cut during the operation;
- Acute cholangitis;
- Serious complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Qi-Yong Lilead
Study Sites (3)
Shulan (Hangzhou) Hospital
Hangzhou, Zhejiang, 310000, China
Quzhou People's Hospital
Quzhou, Zhejiang, China
Shulan (Quzhou) Hospital
Quzhou, Zhejiang, China
Related Publications (15)
Konturek PC, Haziri D, Brzozowski T, Hess T, Heyman S, Kwiecien S, Konturek SJ, Koziel J. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. J Physiol Pharmacol. 2015 Aug;66(4):483-91.
PMID: 26348073BACKGROUNDYu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):527-539. doi: 10.1038/nrgastro.2017.72. Epub 2017 Jul 5.
PMID: 28676707BACKGROUNDMima K, Nakagawa S, Sawayama H, Ishimoto T, Imai K, Iwatsuki M, Hashimoto D, Baba Y, Yamashita YI, Yoshida N, Chikamoto A, Baba H. The microbiome and hepatobiliary-pancreatic cancers. Cancer Lett. 2017 Aug 28;402:9-15. doi: 10.1016/j.canlet.2017.05.001. Epub 2017 May 17.
PMID: 28527946BACKGROUNDMolinero N, Ruiz L, Milani C, Gutierrez-Diaz I, Sanchez B, Mangifesta M, Segura J, Cambero I, Campelo AB, Garcia-Bernardo CM, Cabrera A, Rodriguez JI, Gonzalez S, Rodriguez JM, Ventura M, Delgado S, Margolles A. The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile. Microbiome. 2019 Jul 4;7(1):100. doi: 10.1186/s40168-019-0712-8.
PMID: 31272480BACKGROUNDShen H, Ye F, Xie L, Yang J, Li Z, Xu P, Meng F, Li L, Chen Y, Bo X, Ni M, Zhang X. Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria. Sci Rep. 2015 Dec 2;5:17450. doi: 10.1038/srep17450.
PMID: 26625708BACKGROUNDYe F, Shen H, Li Z, Meng F, Li L, Yang J, Chen Y, Bo X, Zhang X, Ni M. Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts. PLoS One. 2016 Mar 1;11(3):e0150519. doi: 10.1371/journal.pone.0150519. eCollection 2016.
PMID: 26930491BACKGROUNDSwidsinski A, Ludwig W, Pahlig H, Priem F. Molecular genetic evidence of bacterial colonization of cholesterol gallstones. Gastroenterology. 1995 Mar;108(3):860-4. doi: 10.1016/0016-5085(95)90461-1.
PMID: 7875489BACKGROUNDKawai M, Iwahashi M, Uchiyama K, Ochiai M, Tanimura H, Yamaue H. Gram-positive cocci are associated with the formation of completely pure cholesterol stones. Am J Gastroenterol. 2002 Jan;97(1):83-8. doi: 10.1111/j.1572-0241.2002.05425.x.
PMID: 11808974BACKGROUNDKose SH, Grice K, Orsi WD, Ballal M, Coolen MJL. Metagenomics of pigmented and cholesterol gallstones: the putative role of bacteria. Sci Rep. 2018 Jul 25;8(1):11218. doi: 10.1038/s41598-018-29571-8.
PMID: 30046045BACKGROUNDLaw R, Baron TH. ERCP. Gastrointest Endosc. 2013 Sep;78(3):428-33. doi: 10.1016/j.gie.2013.06.018. No abstract available.
PMID: 23948191BACKGROUNDLi QY, Pan L, Ling Q, He JD, Zhang LX, Zheng SS. Single-operator wire-guided cannulation technique enables easier cannulation of endoscopic retrograde cholangiopancreatography. Dig Dis Sci. 2012 Dec;57(12):3293-8. doi: 10.1007/s10620-012-2274-5. Epub 2012 Jun 27.
PMID: 22736016BACKGROUNDLi QY, Chen KJ, Jin J, Zheng SS. Guide wire-assisted technique to access the bile duct with biopsy forceps for repositioning and removal of metal stents. Endoscopy. 2013;45 Suppl 2 UCTN:E273-4. doi: 10.1055/s-0033-1344591. Epub 2013 Sep 5. No abstract available.
PMID: 24008462BACKGROUNDWilliams EJ, Green J, Beckingham I, Parks R, Martin D, Lombard M; British Society of Gastroenterology. Guidelines on the management of common bile duct stones (CBDS). Gut. 2008 Jul;57(7):1004-21. doi: 10.1136/gut.2007.121657. Epub 2008 Mar 5.
PMID: 18321943BACKGROUNDSaito H, Kadono Y, Shono T, Kamikawa K, Urata A, Nasu J, Imamura H, Matsushita I, Tada S. Remaining issues of recommended management in current guidelines for asymptomatic common bile duct stones. World J Gastroenterol. 2021 May 14;27(18):2131-2140. doi: 10.3748/wjg.v27.i18.2131.
PMID: 34025069BACKGROUNDKageoka M, Watanabe F, Maruyama Y, Nagata K, Ohata A, Noda Y, Miwa I, Ikeya K. Long-term prognosis of patients after endoscopic sphincterotomy for choledocholithiasis. Dig Endosc. 2009 Jul;21(3):170-5. doi: 10.1111/j.1443-1661.2009.00880.x.
PMID: 19691764BACKGROUND
Biospecimen
microorganisms in bile
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Qi-Yong Li, doctor
Shulan (Hangzhou) Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
October 20, 2022
First Posted
October 25, 2022
Study Start
September 1, 2022
Primary Completion
June 1, 2023
Study Completion
September 1, 2023
Last Updated
March 20, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share